A Phase II Study of CCX282-B in Patients With Celiac Disease

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether CCX282-B is effective in mitigating the effects of gluten ingestion in patients with celiac disease

Phase 2

ChemoCentryx